Release Details

Workers’ Compensation is the First Private Insurer to Provide Payment for an Exoskeleton

Marlborough, MA — January 22, 2015 — Exoskeleton leader ReWalk Robotics announced today the first reimbursement for a personal exoskeleton system by a private U.S. insurer. This coverage comes from a health plan contracted through Workers’ Compensation in the Midwest region, which has purchased a ReWalk Personal Exoskeleton system for one of its beneficiaries who was injured while at work.

The recipient is a 29 year-old man who suffered a spinal cord injury at work. The man was paralyzed from the waist down during the accident and has been using a wheelchair for more than 7 years. He is in the process of completing the ReWalk training program and will bring his unit home this month.

This reimbursement marks the first Workers’ Compensation payment for an exoskeleton system in the United States, and the second U.S. insurance payment to date. In June 2014, the James J. Peters VA Medical Center in Bronx, NY became the first insurer in the U.S. to provide reimbursement for a ReWalk system to an Army veteran from the Vietnam Era.

“This is a milestone for the paraplegic community in the U.S. who wish to utilize exoskeleton technology in their homes and communities,” said ReWalk CEO Larry Jasinski. “We are thrilled by the support of those insurers contracting with Workers’ Compensation, and the growing number of health care plans worldwide that recognize the benefits of exoskeletons and have followed through with reimbursement.”

ReWalk worked extensively with a case manager overseeing the recipient’s request for purchase. It is through the diligent efforts of the case manager that the recipient will be able to bring his exoskeleton home.

ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk. The system provides user-initiated mobility through the integration of a wearable brace support, a computer-based control system and motion sensors. The system allows independent, controlled walking while mimicking the natural gait patterns of the legs. ReWalk is the only exoskeleton system cleared by the FDA for both personal use as well as use in a rehabilitation setting in the United States. ReWalk has also received regulatory clearances for their systems in several global geographies including: North America, Europe, Asia, the Middle East and Australia.

ReWalk was developed by Dr. Amit Goffer, an Israeli inventor who became quadriplegic after an ATV accident in 1997. It was through his own personal experience in utilizing mobility devices for people with spinal cord injury that Dr. Goffer developed the ReWalk.

About ReWalk Robotics Ltd.

ReWalk Robotics (formerly Argo Medical Technologies) develops, manufactures and markets wearable robotic exoskeletons for people with lower limb disabilities, such as paraplegia. ReWalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. ReWalk is proud to offer the only FDA cleared exoskeleton systems in the United States, for rehab and personal use respectively. Founded in 2001, ReWalk Robotics is a global company with headquarters in the US, Germany, and Israel. For more information on ReWalk Robotics and the ReWalk Systems, please visit http://www.rewalk.com.

Media Contact:
Jennifer Wlach
jwlach@mercuryllc.com
202-551-1454